Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
CJEU Advocate General on Distributors’ Obligations for Medical Devices
Request for a Preliminary Ruling by Federal Court of Justice on the Prohibition of Advertising for Remote Medical Treatments under Section 9 HWG
by multiple authors
by multiple authors
by Katie Chandler and Matthew Caskie
by Irina Rebin
by Irina Rebin